Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating carmustine with and without ethanol in subjects with lymphoma, including Hodgkin and non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carmustine (BiCNU) (carmustine)

Snippet

Sponsor: VIVUS LLC | Conditions: Lymphoma, Non-Hodgkin Lymphoma | Phase 2 | Status: RECRUITING